Topal, A. and Başak, M. (2025) “Evaluating the role of HER2-low versus HER2-0 status in predicting response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer”, The European Research Journal, 11(5), pp. 858–867. doi:10.18621/eurj.1704067.